Israel Englander Infla Rx N.V. Transaction History
Millennium Management LLC
- $224 Billion
- Q1 2024
A detailed history of Israel Englander (Millennium Management LLC) transactions in Infla Rx N.V. stock. As of the latest transaction made, Millennium Management LLC holds 139,957 shares of IFRX stock, worth $243,525. This represents 0.0% of its overall portfolio holdings.
Number of Shares
139,957
Previous 280,932
50.18%
Holding current value
$243,525
Previous $457,000
52.95%
% of portfolio
0.0%
Previous 0.0%
Shares
22 transactions
Others Institutions Holding IFRX
# of Institutions
40Shares Held
13.8MCall Options Held
12.9KPut Options Held
0-
Suvretta Capital Management, LLC New York, NY5.73MShares$9.98 Million0.38% of portfolio
-
Eversept Partners, LP New York, NY1.31MShares$2.27 Million0.15% of portfolio
-
Citigroup Inc1.2MShares$2.09 Million0.0% of portfolio
-
Morgan Stanley New York, NY979KShares$1.7 Million0.0% of portfolio
-
683 Capital Management, LLC New York, NY870KShares$1.51 Million0.11% of portfolio
About InflaRx N.V.
- Ticker IFRX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 44,203,800
- Market Cap $76.9M
- Description
- InflaRx N.V., a clinical-stage biopharmaceutical company, discovers and develops inhibitors using C5a technology primarily in Germany and the United States. The company's C5a is an inflammatory mediator that is involved in the progression of a variety of autoimmune and other inflammatory diseases. Its lead product candidate is vilobelimab, a nov...